Featured Post

Rebuilding Synapses: Neuroplasticity as an Emerging Target in Generalized Anxiety Disorder

August 1, 2026

Classic psychedelics target 5-HT2A receptors, not serotonin transporters. Slow dissociation and intracellular signaling may explain lasting effects seen in GAD.
 Read More

Other top stories

The Receptor at the Center of Psychedelic Therapies for GAD

August 1, 2026

APA 2026: Real-World Gaps in GAD Care and Early Safety Data for DT120

July 27, 2026

Psychedelics Are Advancing in GAD, but None Are Yet Approved

July 16, 2026

The latest news on Depression (MDD)

Six Midlife Depression Signs Tied to Later Dementia Risk

Six Midlife Depression Signs Tied to Later Dementia Risk
SGK1 Emerges as Key Driver (and Target) in Depression

SGK1 Emerges as Key Driver (and Target) in Depression
Too Cold for Comfort? How Your Drink Temp May Affect Your Mood

Too Cold for Comfort? How Your Drink Temp May Affect Your Mood
Energy Insecurity Drives Higher Anxiety, Depression Rates

Energy Insecurity Drives Higher Anxiety, Depression Rates

Other stories

How Generalized Anxiety Disorder Presents, and Why It Is Often Missed

July 7, 2026

Generalized Anxiety Disorder: A Persistent Burden Despite Standard Treatments

July 7, 2026

Why Your Psychiatric Patients Aren’t Sleeping: CBT-I and a Pathway That Finally Works

March 30, 2026

The Sleep Disorder You Are Missing in Your Psychiatric Patients & The Modern Solution For It

March 11, 2026

Brain Training Could Delay Dementia for Years

February 11, 2026

Psychosis Soars in Younger Generations

February 10, 2026

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe